49 related articles for article (PubMed ID: 38488892)
21. PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy Pathway.
Padhani AR; Barentsz J; Villeirs G; Rosenkrantz AB; Margolis DJ; Turkbey B; Thoeny HC; Cornud F; Haider MA; Macura KJ; Tempany CM; Verma S; Weinreb JC
Radiology; 2019 Aug; 292(2):464-474. PubMed ID: 31184561
[TBL] [Abstract][Full Text] [Related]
22. Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review and Meta-analysis.
Kasivisvanathan V; Stabile A; Neves JB; Giganti F; Valerio M; Shanmugabavan Y; Clement KD; Sarkar D; Philippou Y; Thurtle D; Deeks J; Emberton M; Takwoingi Y; Moore CM
Eur Urol; 2019 Sep; 76(3):284-303. PubMed ID: 31130434
[TBL] [Abstract][Full Text] [Related]
23. The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies.
Wegelin O; Exterkate L; van der Leest M; Kummer JA; Vreuls W; de Bruin PC; Bosch JLHR; Barentsz JO; Somford DM; van Melick HHE
Eur Urol; 2019 Apr; 75(4):582-590. PubMed ID: 30522912
[TBL] [Abstract][Full Text] [Related]
24. Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study.
van der Leest M; Cornel E; Israël B; Hendriks R; Padhani AR; Hoogenboom M; Zamecnik P; Bakker D; Setiasti AY; Veltman J; van den Hout H; van der Lelij H; van Oort I; Klaver S; Debruyne F; Sedelaar M; Hannink G; Rovers M; Hulsbergen-van de Kaa C; Barentsz JO
Eur Urol; 2019 Apr; 75(4):570-578. PubMed ID: 30477981
[TBL] [Abstract][Full Text] [Related]
25. Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study.
Rouvière O; Puech P; Renard-Penna R; Claudon M; Roy C; Mège-Lechevallier F; Decaussin-Petrucci M; Dubreuil-Chambardel M; Magaud L; Remontet L; Ruffion A; Colombel M; Crouzet S; Schott AM; Lemaitre L; Rabilloud M; Grenier N;
Lancet Oncol; 2019 Jan; 20(1):100-109. PubMed ID: 30470502
[TBL] [Abstract][Full Text] [Related]
26. Prospective Evaluation of PI-RADS™ Version 2 Using the International Society of Urological Pathology Prostate Cancer Grade Group System.
Mehralivand S; Bednarova S; Shih JH; Mertan FV; Gaur S; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
J Urol; 2017 Sep; 198(3):583-590. PubMed ID: 28373133
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.
Ahmed HU; El-Shater Bosaily A; Brown LC; Gabe R; Kaplan R; Parmar MK; Collaco-Moraes Y; Ward K; Hindley RG; Freeman A; Kirkham AP; Oldroyd R; Parker C; Emberton M;
Lancet; 2017 Feb; 389(10071):815-822. PubMed ID: 28110982
[TBL] [Abstract][Full Text] [Related]
28. Re: PI-RADS version 2: what you need to know.
Scialpi M; Martorana E; Scialpi P; D'Andrea A
Clin Radiol; 2016 Sep; 71(9):934-5. PubMed ID: 27216080
[No Abstract] [Full Text] [Related]
29. Prospective Evaluation of the Prostate Imaging Reporting and Data System Version 2 for Prostate Cancer Detection.
Mertan FV; Greer MD; Shih JH; George AK; Kongnyuy M; Muthigi A; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
J Urol; 2016 Sep; 196(3):690-6. PubMed ID: 27101772
[TBL] [Abstract][Full Text] [Related]
30. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.
Epstein JI; Egevad L; Amin MB; Delahunt B; Srigley JR; Humphrey PA;
Am J Surg Pathol; 2016 Feb; 40(2):244-52. PubMed ID: 26492179
[TBL] [Abstract][Full Text] [Related]
31. PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2.
Weinreb JC; Barentsz JO; Choyke PL; Cornud F; Haider MA; Macura KJ; Margolis D; Schnall MD; Shtern F; Tempany CM; Thoeny HC; Verma S
Eur Urol; 2016 Jan; 69(1):16-40. PubMed ID: 26427566
[TBL] [Abstract][Full Text] [Related]
32. Relationship between non-suspicious MRI and insignificant prostate cancer: results from a monocentric study.
Renard-Penna R; Roupret M; Compérat E; Rozet F; Granger B; Barkatz J; Bitker MO; Lucidarme O; Cussenot O; Mozer P
World J Urol; 2016 May; 34(5):673-8. PubMed ID: 26403663
[TBL] [Abstract][Full Text] [Related]
33. Clinical value of core length in contemporary multicore prostate biopsy.
Lee S; Jeong SJ; Hwang SI; Hong SK; Lee HJ; Byun SS; Choe G; Lee SE
PLoS One; 2015; 10(4):e0123704. PubMed ID: 25875823
[TBL] [Abstract][Full Text] [Related]
34. Length of prostate biopsy cores: does it impact cancer detection?
Fiset PO; Aprikian A; Brimo F
Can J Urol; 2013 Aug; 20(4):6848-53. PubMed ID: 23930611
[TBL] [Abstract][Full Text] [Related]
35. Guidelines on processing and reporting of prostate biopsies: the 2013 update of the pathology committee of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
Van der Kwast T; Bubendorf L; Mazerolles C; Raspollini MR; Van Leenders GJ; Pihl CG; Kujala P;
Virchows Arch; 2013 Sep; 463(3):367-77. PubMed ID: 23918245
[TBL] [Abstract][Full Text] [Related]
36. Tumor lesion diameter on diffusion weighted magnetic resonance imaging could help predict insignificant prostate cancer in patients eligible for active surveillance: preliminary analysis.
Lee DH; Koo KC; Lee SH; Rha KH; Choi YD; Hong SJ; Chung BH
J Urol; 2013 Oct; 190(4):1213-7. PubMed ID: 23727188
[TBL] [Abstract][Full Text] [Related]
37. Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation cohort study with transperineal template prostate mapping as the reference standard.
Arumainayagam N; Ahmed HU; Moore CM; Freeman A; Allen C; Sohaib SA; Kirkham A; van der Meulen J; Emberton M
Radiology; 2013 Sep; 268(3):761-9. PubMed ID: 23564713
[TBL] [Abstract][Full Text] [Related]
38. Prebiopsy magnetic resonance imaging and prostate cancer detection: comparison of random and targeted biopsies.
Delongchamps NB; Peyromaure M; Schull A; Beuvon F; Bouazza N; Flam T; Zerbib M; Muradyan N; Legman P; Cornud F
J Urol; 2013 Feb; 189(2):493-9. PubMed ID: 22982424
[TBL] [Abstract][Full Text] [Related]
39. Core length in prostate biopsy: size matters.
Öbek C; Doğanca T; Erdal S; Erdoğan S; Durak H
J Urol; 2012 Jun; 187(6):2051-5. PubMed ID: 22498214
[TBL] [Abstract][Full Text] [Related]
40. ESUR prostate MR guidelines 2012.
Barentsz JO; Richenberg J; Clements R; Choyke P; Verma S; Villeirs G; Rouviere O; Logager V; Fütterer JJ;
Eur Radiol; 2012 Apr; 22(4):746-57. PubMed ID: 22322308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
